Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong,

Slides:



Advertisements
Similar presentations
For primary and secondary care settings
Advertisements

Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
TEMPLATE DESIGN © Overview: Management Of Ovarian Cancer in Primary Care (1)Fabian Lee, Foundation Year 2. (2) Gbolahan.
Direct Access Flexible Sigmoidoscopy Pathway for GPs
Oesophageal Cancer. -improving outcomes. Anil Kaul Consultant General and Upper GI Surgery St Helens and Knowsley Teaching Hospitals NHS Trust.
School for Primary Care Research Increasing the evidence base for primary care practice The School for Primary Care Research is a partnership between the.
Ian Arnott Consultant Gastroenterologist Western General Hospital Edinburgh The Use of Faecal Calprotectin in Primary Care.
Henrik Møller, Carolynn Gildea, David Meechan, Greg Rubin, Thomas Round, Peter Vedsted Cancer Epidemiology and Population Health, KCL (HM) Public Health.
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
Slides last updated: June 2015 CRC: CLINICAL FEATURES.
Colorectal Pathway North Bristol NHS Trust. Background Colorectal pathway introduced in 2006 Shorten patient pathway Straight to test Reduce routes into.
Direct Access Flexible Sigmoidoscopy
MARK COLEMAN MBChB FRCS (Gen Surg) MD hon FRCPSG Consultant Colorectal Surgeon
Endoscopy Matters NICE guidance dyspepsia, New build, National Context & NAEDI Dr Michelle Gallagher Consultant Gastroenterologist.
Improving Cancer Outcomes in Camden Dr Lucia Grun 15 October 2014.
Flexible Sigmoidoscopy And Whole Colon Imaging In The Diagnosis Of Cancer In Patients With Colorectal Symptoms Peter O’Leary Journal Club 13/10/08.
Diagnosing Iron Deficiency Anaemia in Primary Care Dr Peter Johnson Consultant Haematologist Western General Hospital.
Update The 2 week rule for colorectal cancer Mr Iain Jourdan MS FRCS Director of Surgery Royal Surrey County Hospital.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
[NAME CCG] [DATE] [FACILITATOR] Early Diagnosis of Cancer Quality Improvement using Cancer Significant Event Analysis [CCG MAP]
Caring for people with Dementia who come to the Eye Department Mr Paul G Ursell MBBS MD FRCOphth Royal College of Ophthalmologists Epsom & St Helier University.
Macmillan Ipswich Diagnostic Assessment Service (MIDAS)
FIT Programme (Faecal Immunohistochemical Test)
Implementation of a lung health clinic in high-risk individuals in South East London: a prospective feasibility cohort study Background In 2013, lung cancer.
The Use of Faecal Calprotectin in Primary Care
Screening for Life 2017.
The capacity challenge:
An Electronic 2 Week Wait Referral System for Colorectal Cancer
Cancer Audit Stourport Health Centre Feb 2016
Colorectal Cancer: Risk Prevention and Diagnosis
Vicki Newport RGN BSc Midwifery BSc Advanced Nurse Primary Care
Greg Rubin,1 Nafees Din,2 Richard Neal,2 William Hamilton3
‘Piloting change’ report on the Multi Disciplinary Diagnostic centre
IRRITABLE BOWEL SYNDROME
Jane E Scullion Respiratory Nurse Consultant
‘ACHIEVING WORLD CLASS CANCER OUTCOMES’
Bowel cancer screening update GP education event 28 Nov 2017
Common cancers and NICE
Dr James Carlton, Medical Adviser
Mr Michael Thomas, Colorectal Cancer SSG, 27th June 2018
Achieving World-Class Cancer Outcomes A Strategy for England
BOWEL CANCER SCREENING 11/7/18
Achieving World-Class Cancer Outcomes A Strategy for England
National Cancer Diagnosis Audit
Achieving World-Class Cancer Outcomes A Strategy for England
What to look out for and why?
Making MDTs better Steve Falk
Achieving World-Class Cancer Outcomes A Strategy for England
Achieving World-Class Cancer Outcomes A Strategy for England
Somerset, Wiltshire, Avon & Gloucestershire Cancer Alliance
Colorectal Cancer Cancer Alliance Work
Worcestershire Colorectal Cancer 2ww Pathway
Stockport Together Outpatients Business Case Clinical Engagement Event
Achieving World-Class Cancer Outcomes A Strategy for England
The Use of Faecal Calprotectin in Primary Care
Diagnosing Iron Deficiency Anaemia in Primary Care
Upper Gastrointestinal Cancer
Diagnosis of disease M2/D2
Spinal drop-in service
BOWEL CANCER SCREENING IN LEWISHAM
Assignment 2 Learning Aim D: Individual Treatment Plan
Breath Testing for Gastrointestinal Disease
FIT for symptomatic patients
28 Day Faster Diagnosis Standard
Nursing care of patients operated-on for CRC
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway
Suspected Gynaecological Cancer Recognition & Referral
Colorectal 2 week wait pathways and “Getting FIT”
Northern Cancer Alliance Colorectal Symptoms Assessment Pathway Guidance for investigating colorectal symptoms in primary care including IDA , Faecal.
Faecal Immunochemistry Test - qFIT
Presentation transcript:

Barts Health Trust 2WW Colorectal Workshop Dr Angela Wong, Clinical Director Cancer Consultant Gastroenterologist September 2015

CONTENTS 1. 2Overall Context   1. Cancer Plan 2000 2.Cancer Reform Strategy 2007 3. Improving Outcomes 2. Background 1. introduction 2. Routes to Diagnosis and Survival 3. Bartshealth 2WW 4. NICE guidance 5. Cases 6. STT 7. 2020 8. Conclusion 9. Questions?

1 1 Overall Context

Also 62 upgrade 31 DTT

Background Colorectal 1 2 Background Colorectal

Introduction 4 Colorectal 40,000 new colorectal cancers are diagnosed each year in the UK, up to a quarter of these following screening. A full time GP is likely to diagnose approximately 1 person with colorectal cancer every year. Five year survival is approximately 60%, though this figure includes cancers detected by screening as well as those identified after symptoms have occurred. Symptoms Most common being diarrhoea, constipation (sometimes referred to as ‘change of bowel habit’) rectal bleeding, loss of weight, and abdominal pain. Colorectal cancer may present with anaemia, particularly iron deficiency anaemia.

Routes for diagnosis for diagnosis 27% 2WW scheme (red flag signs) 48% GP/other OP/ routes of referral 25% AE presentation (late with poorer outcomes)

Colorectal Cancer Routes to diagnosis 5 Colorectal Cancer Routes to diagnosis Colorectal 5% 27% 25% 9% 5% 25% 0% 4%

Colorectal Cancer 1YS

1 3 Bartshealth trends

Bartshealth 2WW referral trends 2010-15

Conversion BH colorectal 2WW to cancer

Whipps Cross 2WW referral trends

Conversion 2WW colorectal referrals to cancer

NICE referral guidance 1 4 NICE referral guidance

NICE guidance June 2015 Refer people using a suspected cancer pathway referral (for an appointment within 2 weeks) for colorectal cancer if:  they are aged 40 and over with unexplained weight loss and abdominal pain or  they are aged 50 and over with unexplained rectal bleeding or  they are aged 60 and over with: iron–deficiency anaemia or changes in their bowel habit, or  tests show occult blood in their faeces [new 2015]

Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for colorectal cancer in people with a rectal or abdominal mass. [new 2015] Consider a suspected cancer pathway referral (for an appointment within 2 weeks) for colorectal cancer in adults aged under 50 with rectal bleeding and any of the following unexplained symptoms or findings: ٠abdominal pain ٠change in bowel habit ٠weight loss ٠iron-deficiency anaemia. [new 2015]

FOB Offer testing for occult blood in faeces to assess for colorectal cancer in adults without rectal bleeding who: are aged 50 and over with unexplained: ٠ abdominal pain or ٠weight loss, or ٠ are aged under 60 with ٠changes in their bowel habit or ٠iron-deficiency anaemia or ٠are aged 60 and over and have anaemia even in the absence of iron deficiency. [new 2015]

1 5 Cases

Case 1 22 year old Loose stool Rectal bleeding on and off for 1 year

Case 2 60 male Overt rectal bleeding GP x1, AE x 2 told haemorrhoids Admitted symptomatic anaemia

Case 3 65 yo male Carer Admitted weakness Found to have abnormal LFTs

1 6 STT

Traditional Pathway GP referral Consultant triage Out-patients 8 weeks Lower GI investigation Out-patients 6 weeks 3 months

STT model GP referral Nurse telephone assessment 3 days Lower GI investigation ? Out-patient review 2-4 weeks

1 7 What next 2020?

2020 NHS patients in England should get results for cancer tests within four weeks of being referred by a GP by 2020 under new plans to improve treatment. NHS England's cancer taskforce is also replacing old radiotherapy machines and increasing specialist staff to ensure it delivers "world class" cancer care. The five-year plan will cost £400m a year but experts say earlier treatment will result in similar savings. They say the plan could help an extra 30,000 patients survive for 10 years.

1 8 Conclusion

Conclusion Refer according to guidelines Follow clinical intuition Complete form Explain referred on a cancer pathway Discuss with people with suspected cancer (and their carers as appropriate, taking account of the need for confidentiality) their preferences for being involved in decision-making about referral options and further investigations including their potential risks and benefits. [2015] Explain to people who are being referred with suspected cancer that they are being referred to a cancer service. Reassure them, as appropriate, that most people referred will not have a diagnosis of cancer, and discuss alternative diagnoses with them. [2015] Give the person information on the possible diagnosis (both benign and malignant) in accordance with their wishes for information (see also the NICE guideline on patient experience in adult NHS services). [2015] The information given to people with suspected cancer and Suspected cancer Patient information and support their families and/or carers should cover, among other issues:  where the person is being referred to  how long they will have to wait for the appointment  how to obtain further information about the type of cancer suspected or help before the specialist appointment  what to expect from the service the person will be attending  what type of tests may be carried out, and what will happen during diagnostic procedures  how long it will take to get a diagnosis or test results  whether they can take someone with them to the appointment  who to contact if they do not receive confirmation of an  other sources of support. [new 2015] Provide information that is appropriate for the person in terms of language, ability and culture, recognising the potential for different cultural meanings associated with the possibility of cancer. [new 2015] Have information available in a variety of formats on both local and national sources of information and support for people who are being referred with suspected cancer. For more information on information sharing, see section 1.5 in the NICE guideline on patient experience in adult NHS services. [new 2015] Reassure people in the safety netting group (see recommendation in chapter 5) who are concerned that they may have cancer that with their current symptoms their risk of having cancer is low. [new 2015] Explain to people who are being offered

1 9 Questions?